A groundbreaking study reveals that a single dose of psilocybin, the active compound in magic mushrooms, can provide ...

Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

Scientists have dug up more evidence of the benefits of so-called "magic" mushrooms with the publication of clinical trial results showing how a compound at the root of their nickname leads to ...

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...

A new trial is testing whether psilocybin, the active ingredient in magic mushrooms, can provide relief from depression in cancer patients. It's part of a growing body of research into ...

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder ...